Evaluation of the liver with virtual non-contrast: Single institution study in 149 patients undergoing TAVR planning.
To evaluate accuracy of virtual-non-contrast images (VNC) compared to true-unenhanced-images (TNC) for evaluation of liver attenuation acquired using spectral-detector CT (SDCT). 149 patients that underwent multiphase transcatheter-aortic-valve-replacement (TAVR) SDCT-examinations (unenhanced-chest [TNC], CT-angiography chest [CTA-Chest, early arterial-phase] and abdomen [CTA-Abdomen, additional early arterial-phase after a second injection of contrast media]) were retrospectively included. VNC of CTA-Chest (VNC-Chest) and CTA-Abdomen (VNC-Abdomen) were reconstructed and compared to TNC. ROI-based measurement of mean attenuation (HU) was applied in the following regions: liver, spleen, abdominal aorta and paraspinal muscle. VNC accuracy was high in the liver, spleen, abdominal aorta and muscle for abdomen-scanning. For the liver, average attenuation was 59.0 ± 9.1 HU for TNC and 72.6 ± 9.5 HU for CTA-Abdomen. Liver attenuation in VNC-Abdomen (59.1 ± 6.4 HU) was not significantly different from attenuation in TNC (p > 0.05). In contrast, VNC was less accurate for chest-scanning: Due to the protocol, in CTA-Chest no contrast media was present in the liver parenchyma as indicated by the same attenuation in TNC (59.0 ± 9.1 HU) and CTA-Chest (58.8 ± 8.9 HU, p > 0.05). Liver attenuation in VNC-Chest (56.2 ± 6.4 HU, p < 0.05) was however significantly lower than in TNC and CTA-Chest implying an artificial reduction of attenuation. VNC performed well in a large cohort of TAVR-examinations yielding equivalent mean attenuations to TNC; however, application of this technique might be limited when no or very little contrast media is present in parenchyma, more precisely in an early arterial-phase of the liver. This study showed that VNC can be reliably applied in cardiac protocols when certain limitation are considered.